Research Roundup

Debbie Rigby rounds up the latest in research news Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease Among patients with COPD without exacerbations in the previous year, adherence to once daily dual bronchodilator therapy (umeclidinium/vilanterol) was superior to twice daily ICS/LABA at 12 months. The finding was consistent

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Oral semaglutide as effective as injectable
Next Wesfarmers to ‘rationalise underperforming’ own Priceline stores; briefing